Nifty Midcap 50 News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Indus Towers Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Indus Towers Ltd.
Rating: 3
Author: Motilal Oswal

Keep track of all breaking news and updates on Nifty Midcap 50 from all sources in a single place.

Load latest

Polycab India Ltd.

18 Dec 2025

7617.00

2.39%

Company Update

Polycab India Ltd - 542652 - Clarification With Respect To Increase In Volume

BSE India

clarification with respect to increase in volume

pdf

Polycab India Ltd.

18 Dec 2025

7617.00

2.39%

Company Update

Polycab India Ltd - 542652 - Clarification sought from Polycab India Ltd

BSE India

The Exchange has sought clarification from Polycab India Ltd on December 18, 2025, with reference to Movement in Volume.The reply is awaited.

Hero MotoCorp Ltd.

18 Dec 2025

5695.00

-1.49%

Hero MotoCorp sheds 5%; Jefferies downgrades stock, sees 14% downside risk

Business Standard

Hero MotoCorp share price falls over 5 per cent following reports that foreign brokerage firm Jefferies downgraded stock to 'Underperform' with a downside target of 4,950 per share.

Hero MotoCorp has gained 31.27% in the last 6 Months

Hero MotoCorp Shares Hit One-Month Low After Jefferies Downgrade

NDTV Profit | 18 Dec 2025

Aurobindo Pharma Ltd.

18 Dec 2025

1226.20

0.09%

Aurobindo Pharma's Andhra Arm Gets Form 483 With Five Observations From USFDA

NDTV Profit

The USFDA inspected the unit from December 8 to December 17, 2025, the Hyderabad-based drug firm said in a regulatory filing.

Motilal Oswal increased Buy price target of Aurobindo Pharma Ltd. to 1430.0 on 03 Dec, 2025.

NHPC Ltd.

18 Dec 2025

77.84

1.61%

Company Update

NHPC Ltd - 533098 - Update On Subansiri Lower HE Project (2000 MW) Of NHPC Limited

BSE India

In compliance to Regulation 30 of SEBI LODR, update on successful trial run of Unit 2 (250 MW) of Subansiri Lower HE Project (2000 MW) is submitted. Details given in the attached letter.

pdf

Fortis Healthcare Ltd.

18 Dec 2025

911.65

2.33%

Company Update

Fortis Healthcare Ltd - 532843 - Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For …

BSE India

The relevant disclosure is attached.

pdf

IndusInd Bank Ltd.

18 Dec 2025

858.45

1.63%

IndusInd Bank Under SFIO Probe: What Triggered The Investigation

NDTV Profit

The decision comes even as the Mumbai Police's Economic Offences Wing is set to close its preliminary enquiry after finding no evidence of fund siphoning or diversion.

IndusInd Bank Ltd. has an average target of 776.70 from 12 brokers.

Aurobindo Pharma Ltd.

18 Dec 2025

1226.20

0.09%

Company Update

Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit-IV Of APL Healthcare …

BSE India

Intimation of completion of US FDA inspection at Unit-IV of APL Healthcare Limited Limited, a wholly owned subsidiary of the Company.

pdf

One97 Communications Ltd.

18 Dec 2025

1331.10

-0.37%

Paytm subsidiary receives RBI nod to carry out offline, cross-border payments Details here

livemint

Paytm subsidiary, Paytm Payments Services, on 17 December 2025, received regulatory approval from the Reserve Bank of India to carry out offline and cross-border payments. Here's what you need to know.

One97 Communications.. has an average target of 1561.00 from 5 brokers.

Indus Towers Ltd.

18 Dec 2025

410.90

-0.76%

Risk reward uncompelling despite potential relief for Vi

Neutral: Indus Towers Ltd.

Motilal Oswal

Indus has been gaining market share in new tower builds as well as benefiting from the shift from other towercos in recent quarters, driven by its operational efficiencies and network uptime.

Number of FII/FPI investors decreased from 1007 to 960 in Sep 2025 qtr

Is Nifty Midcap 50 worth buying?

84 Votes:

Buy 63.1%

Sell 23.81%

Hold 13.1%

Nifty Midcap 50 PB	4.6
Nifty Midcap 50 PE	33.7
Nifty Midcap 50 DIV	0.8
Nifty Midcap 50 EPS	511.7